Headlands Technologies’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Buy
67,486
+51,905
+333% +$1.03M 0.14% 183
2026
Q1
$300K Buy
+15,581
New +$307K 0.03% 499
2025
Q4
Sell
-31,159
Closed -$581K 847
2025
Q3
$581K Buy
31,159
+3,438
+12% +$64.2K 0.05% 329
2025
Q2
$511K Buy
+27,721
New +$492K 0.06% 298
2025
Q1
Sell
-11,599
Closed -$201K 1471
2024
Q4
$201K Buy
+11,599
New +$212K 0.02% 524
2024
Q1
Sell
-8,886
Closed -$127K 1495
2023
Q4
$127K Buy
8,886
+5,459
+159% +$77.5K 0.04% 351
2023
Q3
$47.8K Buy
+3,427
New +$43.8K 0.02% 453
2023
Q1
Sell
-188
Closed -$2K 721
2022
Q4
$2K Buy
+188
New +$2.4K ﹤0.01% 453

Other funds holding SBRA

Headlands Technologies's SBRA Position: Q2 2026 in Review

Headlands Technologies increased its Sabra Healthcare REIT (SBRA) stake by 333% in Q2 2026, buying an estimated $1.03M and bringing the position to 67,486 shares worth $1.32M. The position accounts for 0.14% of the portfolio, ranked #183.

Headlands Technologies first reported a position in SBRA in Q4 2022 and has held it in 8 quarters since. 465 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Headlands Technologies held 67,486 shares of Sabra Healthcare REIT worth $1.32M as of Q2 2026.
  • Headlands Technologies bought 51,905 Sabra Healthcare REIT shares in Q2 2026, an estimated $1.03M.
  • Sabra Healthcare REIT made up 0.14% of Headlands Technologies's portfolio in Q2 2026, its #183 holding.
  • Headlands Technologies first reported a position in Sabra Healthcare REIT in Q4 2022 and has held it in 8 quarters since.
  • 465 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Headlands Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.